SCHEMBL17418170

SCHEMBL17418170

CCCOCCCOCCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.46
FFAR3 O14843 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
GPR84 Q9NQS5 7/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
TSHR P16473 6/20 0.44
HDAC11 Q96DB2 5/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 3/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
KMT2A Q03164 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL260630 0.93
SCHEMBL9503728 0.91 AKR1B1 (0.52) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL2949542 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
Hydrochloric Acid SCHEMBL29283245 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL26900519 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL2951087 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL15158837 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL16420210 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL22445018 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2
SCHEMBL2948540 0.91 FFAR3 (0.50) AKR1B1FFAR3HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12466912-B2 Blocked polyisocyanate composition, heat-curable resin composition, cured product, and production method therefor KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-11-11 US disclosed
US-20250215117-A1 METHOD FOR PRODUCING ESTERIFIED POLYSACCHARIDE KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-07-03 US disclosed
EP-4578879-A1 METHOD FOR PRODUCING ESTERIFIED POLYSACCHARIDE Koei Chemical Company, Limited (JP) 2025-07-02 EP disclosed
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20250122323-A1 ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-04-17 US disclosed
US-20250109090-A1 METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-04-03 US disclosed
EP-4530284-A1 METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT Koei Chemical Company, Limited (JP) 2025-04-02 EP disclosed
CN-119707822-A Method for producing onium salt and method for purifying onium salt 广荣化学株式会社 2025-03-28 CN disclosed
CN-118290346-A Method for producing amide compound, and amide compound 广荣化学株式会社 2024-07-05 CN disclosed
CN-112703184-B Method for producing amide compound, and amide compound 广荣化学株式会社 2024-06-11 CN disclosed
WO-2023008572-A1 ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR 広栄化学株式会社 2023-02-02 WO disclosed
CN-115515999-A Blocked isocyanate composition, thermosetting resin composition, cured product and method for producing same, amidated compound, and blocking agent dissociation catalyst for blocked isocyanate 广荣化学株式会社 2022-12-23 CN disclosed
EP-4101845-A1 METHOD FOR PRODUCING CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2022-12-14 EP disclosed
CN-115461386-A Blocked polyisocyanate composition, thermosetting resin composition, cured product, and method for producing same 广荣化学株式会社 2022-12-09 CN disclosed
CN-115052864-A Process for producing carboxylate compound and process for producing amide compound 广荣化学株式会社 2022-09-13 CN disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 EP disclosed
CN-112703184-A Process for producing amide compound, and amide compound 广荣化学株式会社 2021-04-23 CN disclosed
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method KOEI CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD KOEI CHEMICAL COMPANY, LIMITED (JP) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD CEL, CROCC, ALG1 AKR1B1 3813/4885FFAR3 3525/4885HDAC3 1342/4885
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM AKR1B1 2623/4885FFAR3 634/4885HDAC3 604/4885
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method CEL, CROCC, ALG1 AKR1B1 3813/4885FFAR3 3525/4885HDAC3 1342/4885
US-20250109090-A1 METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT NOTUM, CA7, CROCC AKR1B1 1249/4885FFAR3 955/4885HDAC3 675/4885
US-12466912-B2 Blocked polyisocyanate composition, heat-curable resin composition, cured product, and production method therefor THEM6, PUF60, PSMC6 AKR1B1 896/4885FFAR3 111/4885HDAC3 1054/4885
US-20250122323-A1 ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR KDM2B, O60361, IDH3B AKR1B1 805/4885FFAR3 1327/4885HDAC3 1153/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM AKR1B1 2623/4885FFAR3 634/4885HDAC3 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.